Source: Virtual Congress 2020 – Human ex vivo models of interstitial lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
J. Dickens (Cambridge (Cambridgeshire), United Kingdom). The role of cell lines in modelling the type II pneumocyte in interstitial lung disease. Virtual Congress 2020 – Human ex vivo models of interstitial lung disease

Member's Comments

No comment yet.

Related content which might interest you: Evidence of type II pneumocyte apoptosis in the murine model of Hermansky-Pudlak-syndrome associated interstitial pneumonia Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008 The role of biomarkers in management of interstitial lung disease: implications of biomarkers derived from type II pneumocytes Source: Eur Respir Mon; 2009: 46: 47–66 Year: 2009 Aging causes alveolar epithelial type II cell dysfunction in acute lung injury Source: ERS Lung Science Conference 2020 Year: 2020 Refractory remodelling of the microenvironment by type V collagen and apoptosis in non small cell lung cancer Source: Annual Congress 2009 - Pathogenesis of lung cancer Year: 2009 Type V collagen and endothelial apoptosis interface in non small cell lung cancer has impact on prognosis Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 The use of alveolar epithelial type I cell-selective markers to investigate lung injury and repair Source: Eur Respir J 2004; 24 : 664-673 Year: 2004 Effect of hypoxia on gene regulation and differentiation in alveolar epithelial type II cells Source: Eur Respir J 2001; 18: Suppl. 33, 162s Year: 2001 Bleomycin induces cellular senescence in alveolar epithelial cells Source: Eur Respir J 2003; 22: 436-443 Year: 2003 Interstitial lung disease related surfactant protein-C mutations alter the transcriptome and progenitor cell function of alveolar epithelial cells in mice Source: International Congress 2019 – Translational aspects of idiopathic interstitial pneumonia Year: 2019 Krüppel-like Factor 4 is a Stat3-Smad2 regulator in ATII cells determining ATII cell fate during lung development and hyperoxia-induced lung injury Source: International Congress 2019 – Molecular and experimental paediatric lung disease Year: 2019 miR-200 family members reduce senescence and restore idiopathic pulmonary fibrosis type II alveolar epithelial cell transdifferentiation Source: ERJ Open Res, 5 (4) 00138-2019; 10.1183/23120541.00138-2019 Year: 2019 RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: Virtual Congress 2020 – Elucidating the mechanisms underlying lung repair and exploring therapeutic strategies in vitro Year: 2020 PP126 – RANKL contributes to lung tissue repair via promoting type II epithelial cell proliferation Source: ERS Lung Science Conference 2021 Year: 2021 Ex vivo trans-differentiation of primary human alveolar epithelial cells type II by TGFb Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Hyperoxia reversibly inhibits the transdifferentiation of alveolar type II (ATII) cells to alveolar type I (ATI) cells Source: Annual Congress 2005 - Cellular and molecular approaches to lung injury research Year: 2005 The role of apoptosis in pulmonary fibrosis Source: Eur Respir Rev 2008; 17: 138-144 Year: 2008 Increased expression of SARS-CoV-2 (Covid-19) adhesion sites on type II pneumocytes, small airway epithelium, and alveolar macrophages in smokers and patients with COPD Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases Year: 2021 Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis Source: Annual Congress 2013 –Novel mechanisms in lung injury Year: 2013 Effects of static stretch on secretory function and morphology in alveolar epithelial type II cells Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008